Related content

Treatment of immobilization-related hypercalcaemia with denosumab

By Malberti Fabio  

Clinical Kidney Journal, Vol. 5, Iss. 6, 2012-12 ,pp. : 491-495

Oxford University Press

Access to resources Recommend Favorite

Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure

By de Beus Esther   Boer Walther H.  

Clinical Kidney Journal, Vol. 5, Iss. 6, 2012-12 ,pp. : 566-571

Oxford University Press

Access to resources Recommend Favorite

The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab

By Capozzi Anna   Lello Stefano   Pontecorvi Alfredo  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 403-408

Informa Healthcare

Access to resources Recommend Favorite

Prolonged hypocalcaemia following a single dose of 60 mg denosumab in two patients with CKD 4/5 on cinacalcet treatment for tertiary hyperparathyroidism

By Ivanov Petko   Khedr Milad  

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 245-245

Oxford University Press

Access to resources Recommend Favorite

Recombinant PTH associated with hypercalcaemia and renal failure

By Schena F.P.   Ayasreh Nadia   Fernandez-Llama Patricia   Lloret MJ   Da Silva Iara   Ballarín Jose   Bover Jordi  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 93-95

Oxford University Press

Access to resources Recommend Favorite